Editas Medicine (EDIT) Equity Ratio (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Equity Ratio data on file, last reported at 0.15 in Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.15, down 62.78% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.15 (down 62.78% YoY), and the FY2025 annual result was 0.15, down 62.78% from the prior year.
• Equity Ratio improved to 0.15 in Q4 2025 per EDIT's latest filing, from 0.07 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.82 in Q1 2022 and troughed at 0.07 in Q3 2025.
• A 5-year average of 0.6 and a median of 0.7 in 2022 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2021 and 2025: Equity Ratio surged 62.69% in 2021, then plunged 87.56% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.82 in 2021, then decreased by 14.19% to 0.7 in 2022, then retreated by 0.27% to 0.7 in 2023, then tumbled by 43.79% to 0.39 in 2024, then plunged by 62.78% to 0.15 in 2025.
• Business Quant data shows EDIT's Equity Ratio at 0.15 in Q4 2025, 0.07 in Q3 2025, and 0.09 in Q2 2025.